STYLE SHEET
GLOBAL CSS
COLORS
ANIMATIONS
MEDIA QUERY
SPACING SYSTEM

News

Stay informed with our latest news posts.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
News
Popular drug linked to reduced dementia risk in elderly with diabetes

Study shows GLP-1 agonists reduce dementia risk in elderly with type 2 diabetes. Findings from KI highlight potential benefits for diabetes treatment

News
WHO: Medical Product Alert: Fake Ozempic (semaglutide)

Medical Product Alert: Fake Ozempic (semaglutide) Detected in Americas and Europe

News
Wigan named UK's 'Fattest Town' - Yazen Health tackles obesity safely

Wigan named UK's 'Fattest Town' - Yazen Health tackles obesity safely

News
Dr. Punam Krishan debunks myths surrounding obesity

Dr. Punam Krishan debunks myths surrounding obesity

Press release
What care do the morbidly obese individuals need?

The obesity epidemic is one of the greatest health challenges of our time. Globally, it is estimated that 1.9 billion people will suffer from morbid obesity by 2035, which represents one in four adults. Among children, obesity is expected to increase by 100 percent between 2020 and 2035. The cost to society is projected to be 4 trillion dollars.

Yazen participates in roundtable with Health Tech World

Martin Carlsson participates in "Where next for digital health? A roundtable debate hosted by Health Tech World

News
Yazen transforms the accessibility of obesity treatment

Yazen tackles the challenge with groundbreaking, accessible, and comprehensive treatment approach

News
Shortages and concerns arise as weight-loss injections gain popularity

Weight-loss injections like Ozempic and Wegovy have gained significant attention, European startups entering market

Press release
Yazen's weight control success: 60 tonnes shed!

Patients at the digital healthcare provider Yazen have now collectively shed 60 tonnes

No results found.
There are no results with this criteria. Try changing your search.